Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings

Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings

Glucagon-like peptide-1 receptor agonists (GLP-1RA) have a more potent glycated hemoglobin (HbA1c)-lowering effect than existing therapies and are widely used for treating type 2 diabetes mellitus (T2DM). Once-daily oral semaglutide is the world’s first oral GLP-1RA. This study aimed to provide real...

Full description

Bibliographic Details
Main Authors: Hodaka Yamada, Masashi Yoshida, Shunsuke Funazaki, Jun Morimoto, Shiori Tonezawa, Asuka Takahashi, Shuichi Nagashima, Kimura Masahiko, Otsuka Kiyoshi, Kazuo Hara
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
glucagon-like peptide-1 receptor agonist
oral semaglutide
type 2 diabetes mellitus
real-world data
cardiometabolic risk factors
Online Access:https://www.mdpi.com/2308-3425/10/4/176

Internet

https://www.mdpi.com/2308-3425/10/4/176

Similar Items